Affiliated Hospital To Academy Of Military Medical Sciences
Clinical trials sponsored by Affiliated Hospital To Academy Of Military Medical Sciences, explained in plain language.
-
New Two-Pronged attack on tough blood cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy designed to fight high-risk plasma cell cancers, like an aggressive form of multiple myeloma. The therapy is engineered to target two specific markers (BCMA and CD70) on cancer cells. The main goals are to check t…
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New Two-Target cell therapy tested for Tough-to-Treat blood cancers
Disease control Not yet recruitingThis early-phase study is testing a new type of CAR-T cell therapy designed to target two markers (CD19 and BCMA) on cancer cells. It aims to see if this treatment is safe and effective for adults with advanced plasma cell cancers, like multiple myeloma, that have come back or st…
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC